Advertisement TomoTherapy to acquire assets of Hi-Art of Japan - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

TomoTherapy to acquire assets of Hi-Art of Japan

TomoTherapy has entered into a memorandum of understanding to acquire certain assets of Hi-Art relating to the sales and service of TomoTherapy's products in Japan.

Over the next several weeks, TomoTherapy and Hi-Art will negotiate a definitive purchase agreement. The transaction is expected to close in the fourth quarter of 2008, at which time the current distribution agreement will cease.

Fred Robertson, CEO of TomoTherapy, said: “As TomoTherapy grows, we continue to assess how we can best serve our customers in all markets. This move in Japan reflects our commitment to our current and future Japanese customers.”